Aarti Drugs Revenue vs. EBITDA
| AARTIDRUGS | 460.80 2.40 0.52% |
For Aarti Drugs profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aarti Drugs to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aarti Drugs Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aarti Drugs's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aarti Drugs Limited over time as well as its relative position and ranking within its peers.
Aarti |
Aarti Drugs Limited EBITDA vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Aarti Drugs's current stock value. Our valuation model uses many indicators to compare Aarti Drugs value to that of its competitors to determine the firm's financial worth. Aarti Drugs Limited is the top company in revenue category among its peers. It also is number one stock in ebitda category among its peers totaling about 0.13 of EBITDA per Revenue. The ratio of Revenue to EBITDA for Aarti Drugs Limited is roughly 7.72 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aarti Drugs' earnings, one of the primary drivers of an investment's value.Aarti Revenue vs. Competition
Aarti Drugs Limited is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 88.98 Billion. Aarti Drugs totals roughly 25.09 Billion in revenue claiming about 28% of equities under Health Care industry.
Aarti EBITDA vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Aarti Drugs |
| = | 25.09 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Aarti Drugs |
| = | 3.25 B |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Aarti EBITDA Comparison
Aarti Drugs is currently under evaluation in ebitda category among its peers.
Aarti Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Aarti Drugs. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aarti Drugs position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aarti Drugs' important profitability drivers and their relationship over time.
Use Aarti Drugs in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aarti Drugs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarti Drugs will appreciate offsetting losses from the drop in the long position's value.Aarti Drugs Pair Trading
Aarti Drugs Limited Pair Trading Analysis
The ability to find closely correlated positions to Aarti Drugs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aarti Drugs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aarti Drugs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aarti Drugs Limited to buy it.
The correlation of Aarti Drugs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aarti Drugs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aarti Drugs Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aarti Drugs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Aarti Drugs position
In addition to having Aarti Drugs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Long Short Funds Thematic Idea Now
Long Short Funds
Funds or Etfs that are designed to hedge away market risk by investing in combination of bonds, stocks, derivative instruments as well as short positions to maximize returns irrespective of market conditions. The Long Short Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long Short Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Aarti Stock Analysis
When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.